GENGRAF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gengraf, and what generic alternatives are available?
Gengraf is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in GENGRAF is cyclosporine. There are eighteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gengraf
A generic version of GENGRAF was approved as cyclosporine by HIKMA on October 29th, 1999.
Summary for GENGRAF
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 37 |
Patent Applications: | 3,365 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GENGRAF |
DailyMed Link: | GENGRAF at DailyMed |
Recent Clinical Trials for GENGRAF
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 1/Phase 2 |
Fred Hutchinson Cancer Research Center | Phase 1/Phase 2 |
National Institutes of Health (NIH) | Phase 2 |
Pharmacology for GENGRAF
Drug Class | Calcineurin Inhibitor Immunosuppressant |
Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
US Patents and Regulatory Information for GENGRAF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | GENGRAF | cyclosporine | CAPSULE;ORAL | 065003-001 | May 12, 2000 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | GENGRAF | cyclosporine | CAPSULE;ORAL | 065003-002 | May 12, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | GENGRAF | cyclosporine | CAPSULE;ORAL | 065003-003 | May 12, 2000 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |